8AR0

Solution structure of TLR2 transmembrane and cytoplasmic juxtamembrane regions

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
5	2D 1H-13C HSQC aliphatic	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
7	2D 1H-13C HSQC aliphatic constant time	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
6	2D 1H-13C HSQC aromatic	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
3	3D HNCO	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
4	3D HN(CO)CA	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
2	3D HNCA	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
8	3D HCCH-TOCSY	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
9	3D HCCH-TOCSY	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
17	3D HCcH-TOCSY constant time	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
16	3D hCCH-TOCSY constant time	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
10	3D 1H-15N NOESY	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
11	3D 1H-13C NOESY aliphatic	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
14	3D 1H-13C NOESY aliphatic constant time	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
12	3D HCCH-COSY aromatic	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
13	2D CBHD aromatic	200 uM [U-13C; U-15N] protein, 23.27 mM DMPC, 5.87 mM DMPG, 78.16 mM DHPC, 20 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP	95% H2O/5% D2O	50 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
18	2D 1H-15N IPAP-HSQC	188 uM [U-15N] protein, 24.23 mM DMPC, 5.50 mM DMPG, 80.18 mM DHPC, 50 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP, 30 mg/mL dGpG, 100 mM potassium chloride	95% H2O/5% D2O	235 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600
19	2D 1H-15N HSQC	188 uM [U-15N] protein, 24.23 mM DMPC, 5.50 mM DMPG, 80.18 mM DHPC, 50 mM potassium phosphate, 4 mM TCEP, 0.05 % w/v sodium azide, 1 mM TSP, 30 mg/mL dGpG, 100 mM potassium chloride	95% H2O/5% D2O	235 mM	7.0	AMBIENT atm	318	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.13	Peter Guentert
2	processing	TopSpin	3.0	Bruker Biospin
3	chemical shift assignment	CARA	1.9.7.1	Keller and Wuthrich
4	peak picking	CARA	1.9.7.1	Keller and Wuthrich
5	processing	qMDD	3.2	Maxim Mayzel, Krzysztof Kazimierczuk, Vladislav Orekhov
6	data analysis	MOLMOL		Koradi, Billeter and Wuthrich
7	data analysis	PyMOL		Schrodinger, Inc.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.